Related Experiment Video
Updated: Jan 8, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Behçet's Disease Mimicking Drug-Induced Mucocutaneous Lesions in a Patient on Anti-tuberculous Drugs
Maha Batool1, Imman Akram2, Farah Babar2
1Internal Medicine, Gulab Devi Teaching Hospital, Lahore, PAK.
Abstract:
Behçet's disease is an inflammatory disease characterized by recurrent oral aphthous ulcers and numerous potential systemic manifestations. These include genital ulcers, skin lesions, and diseases affecting the eyes, nervous system, blood vessels, joints, and gastrointestinal tract. The underlying cause of the disease is unknown. As with other autoimmune diseases, the disorder may represent aberrant immune activity triggered by exposure to an agent, perhaps infectious, in patients with a genetic predisposition to develop the disease. We present the case of a 30-year-old male who developed features consistent with Behçet's disease, including ocular, genital, and oral involvement, following treatment for presumed tuberculosis with anti-tuberculous therapy (ATT). As the oral aphthous ulcers are common in the general population and Behçet's disease is relatively rare, the diagnosis should be considered in the context of recurrent aphthous ulcers accompanied by other systemic manifestations. There is no pathognomonic laboratory test for Behçet's disease; therefore, the diagnosis is primarily clinical and meets the International Criteria for Behçet's Disease (ICBD) criteria. A score of 4 or more points is considered diagnostic. This publication underscores that Behçet's disease is frequently misdiagnosed or mismanaged because of its overlapping clinical features with other disorders. Moreover, infectious triggers may, in some cases, contribute to the onset or unmasking of the disease.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

